205 related articles for article (PubMed ID: 22319031)
21. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
[TBL] [Abstract][Full Text] [Related]
22. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
23. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy).
Sato K
Endocr J; 2008 Dec; 55(6):959-66. PubMed ID: 18614854
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
[TBL] [Abstract][Full Text] [Related]
25. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
28. Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.
Parfitt AM; Schipani E; Rao DS; Kupin W; Han ZH; Jüppner H
J Clin Endocrinol Metab; 1996 Oct; 81(10):3584-8. PubMed ID: 8855805
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
Kamp K; Feelders RA; van Adrichem RC; de Rijke YB; van Nederveen FH; Kwekkeboom DJ; de Herder WW
J Clin Endocrinol Metab; 2014 Sep; 99(9):3060-9. PubMed ID: 24905065
[TBL] [Abstract][Full Text] [Related]
30. [Malignancy-associated hypercalcemia].
Yamaguchi K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
[TBL] [Abstract][Full Text] [Related]
31. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.
Iliuta IA; Beauregard JM; Couture F; Douville P; Mac-Way F
Clin Nucl Med; 2015 Sep; 40(9):e448-50. PubMed ID: 26053724
[TBL] [Abstract][Full Text] [Related]
32. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
33. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
[TBL] [Abstract][Full Text] [Related]
34. Hypercalcemia mediated by parathyroid hormone-related protein as an early manifestation of pancreatic adenocarcinoma metastasis: a case report.
Rasnake MS; Glanton C; Ornstein D; Osswald M; Garrison M
Am J Clin Oncol; 2001 Aug; 24(4):416-7. PubMed ID: 11474277
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic hypercalcemia with adenosquamous carcinoma of the colon.
Fujita T; Fukuda K; Nishi H; Takao T; Ohmura Y; Mano M; Komatsubara S
Int J Clin Oncol; 2005 Apr; 10(2):144-7. PubMed ID: 15864702
[TBL] [Abstract][Full Text] [Related]
36. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
39. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
Stewart AF
J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma.
Suwaki N; Masuyama H; Mizutani Y; Kodama J; Hiramatsu Y
J Obstet Gynaecol Res; 2006 Feb; 32(1):94-8. PubMed ID: 16445533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
